BlackRock Health Sciences Trust
BME
Market Cap$544.65M
Close$
$-0.27
100.7% downside
Current Fair Value
100.7% downsideOvervalued by 100.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $544.65 Million |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $2.4832 (6.36%) |
| Earnings per Share | $0.0 |
| Beta | 0.0 |
| Outstanding Shares | 13,943,973 |
| Avg 30 Day Volume | 32,863 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
ESG Score
No data
About BlackRock Health Sciences Trust
CEO: John Perlowski BlackRock Health Sciences Trust’s (BME) (the 'Trust') investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment ob...